AlphaYouLA
Insider selling
Lori Anne Kunkel sold $505K of Enliven Therapeutics, Inc. (ELVN) stock
Lori Anne Kunkel, Dir of Enliven Therapeutics, Inc. (ELVN), sold 10,000 shares of ELVN stock worth $505K, per an SEC Form 4 filed Jul 8, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 6, 2026, 2 days before it was made public.
ELVN has moved -2.3% since the trade date, from $50.01 to $48.87 (Sep 21, 2026 close).
- Traded
- Jul 6, 2026
- Disclosed
- Jul 8, 2026
- Filing delay
- 2 days
- Price since
- -2.3%
- Role
- Dir
- Source
- SEC Form 4
More ELVN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.